Overall, inflammatory signaling pathways are key drivers of CRC (Lasry et al., 2016), and miR-21appears to be a key modulator of several pro-oncogenic and immunomodulatory factors,such as PDCD4, NFΚB, and STAT3. The gene discussed is PDCD4; the disease is colorectal carcinoma.